# § 721.10829   Xanthylium, x-[2-(alcoxycarbonyl)phenyl]-bis(alkylamino)-dimethyl-, x′-[x″ -[hydroxy-x″′-[[[[hydroxy-x′′′′-(phenyldiazenyl)-sulfo-2-naphthalenyl] amino]carbonyl]amino]sulfo- naphthalenyl]diazenyl]benzoate, sodium salt (generic).

(a) *Chemical substance and significant new uses subject to reporting.* (1) The chemical substance identified generically as xanthylium, x-[2-(alcoxycarbonyl)phenyl]-bis(alkylamino)-dimethyl-, x′-[x″ -[hydroxy-x″′-[[[[hydroxy-x′′′′-(phenyldiazenyl)-sulfo-2-naphthalenyl] amino]carbonyl]amino]sulfo- naphthalenyl]diazenyl]benzoate, sodium salt (PMN P-14-800) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.


(2) The significant new uses are:


(i) *Release to water.* Requirements as specified in § 721.90(a)(4), (b)(4), and (c)(4) (N = 1).


(ii) [Reserved]


(b) *Specific requirements.* The provisions of subpart A of this part apply to this section except as modified by this paragraph.


(1) *Recordkeeping.* Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers and processors of this substance.


(2) *Limitations or revocation of certain notification requirements.* The provisions of § 721.185 apply to this section.



---

[N] [80 FR 26460, May 8, 2015]




